NCT04080518View on ClinicalTrials.gov

Hepato-renal Regulation of Water Conservation in Heart Failure Patients With SGLT-2 Inhibitor Treatment

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 11, 2019

Primary Completion Date

November 10, 2021

Study Completion Date

November 10, 2021

Conditions

Diabetes MellitusHeart Failure

Interventions

DRUG

Dapagliflozin 10 MG [Forxiga]

24 Hour Urine Collection, Sodium (23Na) MRI and Magnetic Resonance (MR) spectroscopy scan, Blood collection for metabolomic and osmolyte analysis

Trial Locations (1)

169609

National Heart Centre Singapore, Singapore

All Listed Sponsors

collaborator

Duke-NUS Graduate Medical School

OTHER

lead

National Heart Centre Singapore

OTHER

NCT04080518 - Hepato-renal Regulation of Water Conservation in Heart Failure Patients With SGLT-2 Inhibitor Treatment | Biotech Hunter | Biotech Hunter